Delivery Order SPE2DR25D3501-SPE2DR26FM2AP
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,402.33 to AmerisourceBergen Drug Corp for the supply of Tham 18 gram/500 mL solution in 500 mL quantities. This competitively awarded, firm fixed-price delivery order was issued on August 5, 2025, with an ultimate completion date of August 6, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $19,176.36 delivery order to AmerisourceBergen Drug Corp on December 29, 2025, for the supply of Revlimid 10 mg capsules (28-count units). This competitively awarded, firm fixed price delivery order is scheduled for completion by January 21, 2026, and will be performed at the contractor's Conshohocken, Pennsylvania location. The award was not designated as a set-aside contract. This delivery order is issued under AmerisourceBergen Drug Corp's broader...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 8, 2025, for the supply of Revlimid 5 mg capsules (28-count) with a ceiling value of $12,329.15. This is a firm fixed price, competitively awarded delivery order with no set-aside designation and an ultimate completion date of October 30, 2025. The order will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of Revlimid 25 mg capsules (100-count units) under a firm fixed-price contract valued at $52,487.80, with completion expected by September 26, 2025. This non-competitive delivery order represents a continuation of the company's critical role as a pharmaceutical supplier to the federal government. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a...
- The Defense Logistics Agency awarded a delivery order valued at $73,936.00 to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Revlimid 10 mg capsules (quantity: 28 units). This competitive award, issued under firm fixed price terms, specifies a place of performance in Conshohocken, Pennsylvania, with an ultimate completion date of October 20, 2025. The contract carries no set-aside designation, indicating the award was made through open competition. This delivery order is...
- The Defense Logistics Agency awarded a $14.5K delivery order to AmerisourceBergen Drug Corp on December 19, 2025, for the supply of Revlimid 25 mg capsules (quantity 21). This competitively awarded, firm fixed-price order is classified as a child contract with an ultimate completion date of January 13, 2026, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. No set-aside designation was utilized for this procurement. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on April 24, 2025, for the supply of Teriflunomide 14 mg tablets (28-count packaging) with a ceiling value of $9,160.13. This is a firm fixed price delivery order with no set-aside designation, awarded through competitive procedures. The order is scheduled for ultimate completion by April 25, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a $24,963.40 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the supply of REVLIMID 5 MG CAPSULE 28S, a pharmaceutical product, and has an ultimate completion date of October 3, 2024. This order is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for...
- The Defense Logistics Agency awarded a delivery order valued at $52,575.49 to AmerisourceBergen Drug Corp for 100 capsules of REVLIMID 10 mg on August 8, 2025, with an ultimate completion date of August 29, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's broader pharmaceutical supply framework with DLA. The pharmaceutical product will be delivered to the company's corporate office location in...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $57,546.06 to AmerisourceBergen Drug Corp for the supply of Teriflunomide 14 mg tablets (30-count units) under a firm fixed-price contract. The delivery order was competitively awarded without set-aside provisions and is set for completion by November 14, 2025. AmerisourceBergen Drug Corp will perform this work from its corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- SPE2DR25D3501Indefinite Delivery Contract
- SPE2DR25D3501-SPE2DR26FM2APDelivery Order
The Defense Logistics Agency awarded a $5,575.86 delivery order to AmerisourceBergen Drug Corp on January 8, 2026, for the supply of Thalomid (thalidomide) 100 mg capsules in quantities of 28 units. The award is a firm fixed-price contract with no set-aside designation, indicating it was competitively awarded. The place of performance is located in Conshohocken, Pennsylvania, with an ultimate completion date of January 30, 2026. AmerisourceBergen Drug Corp operates as a subsidiary of Cencora, Inc. (doing business as AmerisourceBergen), a major pharmaceutical distributor serving federal healthcare systems. This delivery order operates under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The parent IDC serves as a comprehensive global pharmaceutical supply vehicle enabling the company to deliver a broad range of medications, including specialty drugs, vaccines, and medical supplies to support military healthcare programs worldwide. The contract supports critical medical procurement for the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems as part of DLA's pharmaceutical supply chain operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.6k | 1/7/26 |